Sponsor:
GentiBio, Inc
Code:
NCT06860516
Conditions
Diabetes Mellitus, Type I
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
blood draw or cheek swab
Brief summary:
Conditions
Diabetes Mellitus, Type I
Study ID
NCT06860516
Start date
Jun 6, 2025
Status verified date
Aug, 2026
Completion date
Mar, 2027
Anticipated
Primary completion date
Jan 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Arms
all participants
Interventions
blood draw or cheek swab
Primary outcome measure
Central contacts
Locations
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94158
Contacts
Principal Investigator:
Stephen Gitelman, MD
University of Florida- Gainesville
Recruiting
Gainesville, Florida, United States, 32610
Contacts
Principal Investigator:
Michael Haller, MD
Joslin Diabetes Center
Recruiting
Boston, Massachusetts, United States, 02215
Contacts
Principal Investigator:
Jason Gaglia, MD
Icahn School of Medicine at Mount Sinai
Recruiting
New York, New York, United States, 10029
Contacts
Sarah Rancic
sarah.rancic@mssm.eduPrincipal Investigator:
Carol Levy, MD
University of North Carolina at Chapel Hill
Recruiting
Chapel Hill, North Carolina, United States, 27514
Contacts
Principal Investigator:
Klara Klein, MD
Sponsor
GentiBio, Inc
Last update posted
Aug 28, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by GentiBio, Inc on 2026-08-28.